Your session is about to expire
← Back to Search
RST-001 for Retinitis Pigmentosa
Study Summary
This trial is testing an experimental treatment for macular degeneration. It is enrolling 12 patients total, 6 of which must have very poor vision in the study eye, and 6 of which must have vision ranging from poor to 20/200.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am 18 years old or older.I am 18 years old or older.To be a participant in the study, you must meet all of the following criteria: be a smoker, be at least 18 years old, and live in the United States.They are able to comply with all the testing requirements and protocols.I cannot or do not want to follow the study's requirements.
- Group 1: Group 1
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are there numerous facilities administering the experiment within this state?
"At present, 4 medical centres are recruiting for this trial. Dallas, San Francisco and Cincinnati have established locations where patients can participate in the study while other cities house additional potential sites of enrolment. To reduce travelling burdens it is recommended to choose the closest location available when enrolling."
Is the recruitment process for this clinical trial currently underway?
"Clinicaltrials.gov shows that this research project is no longer accepting participants, as the last update to its posting was made on September 9th 2022. Despite this trial being inactive, there are 51 other trials actively recruiting patients at present time."
Who else is applying?
What state do they live in?
How old are they?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Share this study with friends
Copy Link
Messenger